Cargando…
Postoperative adjuvant aspirin for patients with hepatitis B virus-related hepatocellular carcinoma and portal vein tumor thrombus: An open-label, randomized controlled trial
PURPOSE: To compare the survival outcomes of postoperative adjuvant aspirin with surgery alone in patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) and portal vein tumor thrombus (PVTT). METHODS: From June 2013 to July 2015, an open-label, randomized controlled study was c...
Autores principales: | Lu, Chong-De, Jiang, Ya-Bo, Feng, Jin-Kai, Wang, Lei, Wei, Xu-Biao, Zhou, Bin, Lin, Xiao-Lu, Guo, Wei-Xing, Lau, Wan Yee, Cheng, Shu-Qun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559736/ https://www.ncbi.nlm.nih.gov/pubmed/37810112 http://dx.doi.org/10.1016/j.heliyon.2023.e20015 |
Ejemplares similares
-
Portal vein tumor thrombus is a bottleneck in the treatment of hepatocellular carcinoma
por: Sun, Ju-Xian, et al.
Publicado: (2016) -
The efficacy and safety of postoperative adjuvant transarterial embolization and radiotherapy in hepatocellular carcinoma patients with portal vein tumor thrombus
por: Bai, Tao, et al.
Publicado: (2016) -
Postoperative adjuvant chemo (embolization) therapy for hepatocellular carcinoma with portal vein tumor thrombosis
por: Zhang, Ya-Fei, et al.
Publicado: (2018) -
Postoperative adjuvant TACE-associated nomogram for predicting the prognosis of resectable Hepatocellular Carcinoma with portal vein Tumor Thrombus after Liver Resection
por: Liu, Fuchen, et al.
Publicado: (2020) -
Neoadjuvant Three-Dimensional Conformal Radiotherapy for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Randomized, Open-Label, Multicenter Controlled Study
por: Wei, Xubiao, et al.
Publicado: (2019)